Trial Profile
A study evaluating pharmacokinetic variability of Lacosamide in relation to efficacy and tolerability
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2020
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 30 Apr 2018 New trial record